NSEAgreements6 Aug 2026 · 6 Aug 2026, 09:17 am

Agreements

Inventurus Knowledge Solutions Limited · IKS

✦ AI SummaryResults

Inventurus Knowledge Solutions Limited has informed the Exchange about disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Details of the Stock Purchase Agreement for sale of Series A-1 Preferred Shares held by Inventurus Knowledge Solutions, Inc. in Abridge AI Inc.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Inventurus Knowledge Solutions Limited has informed the Exchange about disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Details of the Stock Purchase Agreement for sale of Series A-1 Preferred Shares held by Inventurus Knowledge Solutions, Inc. in Abridge AI Inc.

Attachments (1)

📄

IKS2006_06082026091624_StockExchDiclosureAbridgeIncsaleofShares_FinalV2.pdf

pdf

Download →
View document text
August 06, 2026 BSE Limited National Stock Exchange of India Limited The Listing Department The Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G Block, 25th Floor, Dalal Street Bandra Kurla Complex Fort, Mumbai 400 001 Bandra (East), Mumbai 400051 Maharashtra, India Maharashtra, India BSE Scrip Code: 544309 NSE Symbol: IKS Dear Sir/Ma’am, Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Details of the Stock Purchase Agreement for sale of Series A-1 Preferred Shares held by Inventurus Knowledge Solutions, Inc. in Abridge AI Inc. Pursuant to the provisions of Regulations 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), we hereby inform you that Inventurus Knowledge Solutions, Inc. ("IKS Inc."), a wholly owned subsidiary of Inventurus Knowledge Solutions Limited (the "Company"), has entered into a Stock Purchase Agreement ("SPA") dated August 05, 2026, with Alpha Square Group Fund IV, LP (the "Purchaser") for the sale of certain Series A-1 Preferred Shares of Abridge AI Inc held by IKS Inc. The relevant disclosures as required under Regulation 30 of the SEBI LODR Regulations and Part A of Schedule III thereof, read with SEBI Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 (Master Circular for compliance with the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 by listed entities) dated January 30, 2026, is enclosed herewith as Annexure - A. We request you to take the same on your records Yours sincerely, For Inventurus Knowledge Solutions Limited Sameer Chavan Company Secretary and Compliance Officer Membership No. F7211 Encl: As above Inventurus Knowledge Solutions Limited Registered Address: 801, Building No. 5, 8th Floor, Mindspace Business Park (SEZ), Thane-Belapur Road, Airoli, Navi Mumbai – 400708, Thane, Maharashtra, India Ph.: +91 22 3071 1100 | W: www.ikshealth.com | CIN: L72200MH2006PLC337651 Annexure – A DISCLOSURE UNDER REGULATION 30 OF THE SEBI LODR REGULATIONS READ WITH SEBI CIRCULAR NO. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 DATED JANUARY 30, 2026 Details of the Stock Purchase Agreement for sale of Series A-1 Preferred Shares held by Inventurus Knowledge Solutions, Inc. in Abridge AI Inc. S. Particulars Description 1. Name(s) of parties with whom The parties to the Stock Purchase Agreement (“SPA”) are as follows: the agreement is entered 1. Seller - Inventurus Knowledge Solutions, Inc. (a wholly owned subsidiary of the Company) (“IKS Inc”) of Inventurus Knowledge Solutions Limited (“the Company”). 2. Purchaser - Alpha Square Group Fund IV, LP 3. Confirming Party - Abridge AI Inc 2. Purpose of entering into the Monetization/partial divestment of Series A-1 Preferred Shares held by agreement IKS Inc in Abridge AI Inc 3. Size of agreement USD 10,000,175/-. 4. Shareholding, if any, in the entity Not applicable. with whom the agreement is executed 5. Significant terms of the Sale of 54,055 Series A-1 Preferred Shares for an aggregate agreement (in brief) special consideration of USD 10,000,175/-. rights like right to appoint directors, first right to share subscription in case of issuance of shares, right to restrict any change in capital structure etc. 6. Whether the said parties are None of the parties to the SPA form part of or are related to the related to promoter/promoter promoters/ promoter group/group companies of the Company. group/ group companies in any manner. If yes, nature of relationship 7. Whether the transaction would No fall within related party transactions? If yes, whether the same is- done at "arms length" 8. In case of issuance of shares to Not Applicable the parties, details of issue price, class of shares issued 9. in case of loan agreements, Not Applicable details of lender/borrower, Inventurus Knowledge Solutions Limited Registered Address: 801, Building No. 5, 8th Floor, Mindspace Business Park (SEZ), Thane-Belapur Road, Airoli, Navi Mumbai – 400708, Thane, Maharashtra, India Ph.: +91 22 3071 1100 | W: www.ikshealth.com | CIN: L72200MH2006PLC337651 nature of the loan, total amount of loan granted/taken, total amount outstanding, date of execution of the loan agreement/sanction letter, details of the security provided to the lenders / by the borrowers for such loan or in case outstanding loans lent to a party or borrowed from a party become material on a cumulative basis 10. Any other disclosures related to Not Applicable such agreements, viz., details of nominee on the board of directors of the listed entity, potential conflict of interest arising out of such agreements, etc. 11. In case of termination or Not Applicable amendment of agreement, listed entity shall disclose additional details to the stock exchange(s): i. name of parties to the agreement; ii. nature of the agreement; iii. date of execution of the agreement; iv. details of amendment and impact thereof or reasons of termination and impact thereof. Inventurus Knowledge Solutions Limited Registered Address: 801, Building No. 5, 8th Floor, Mindspace Business Park (SEZ), Thane-Belapur Road, Airoli, Navi Mumbai – 400708, Thane, Maharashtra, India Ph.: +91 22 3071 1100 | W: www.ikshealth.com | CIN: L72200MH2006PLC337651